Condition
Cirrhoses, Liver clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Cirrhoses, Liver clinical trials that are recruiting, at sites in 4 countries (most in China (2), France (1), Pakistan (1)). By phase: Phase 2 (1), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 4Countries
Newest Cirrhoses, Liver clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Allopurinol to prevent complications in decompensated liver cirrhosis | Phase 4 | Dhaka, Shahbagh and 1 other locations | Recruiting | Sep 2, 2026 |
| Vonoprazan to prevent ulcers after endoscopic variceal band ligation | Phase 2 | Lahore, Punjab Province | Recruiting | Dec 5, 2025 |
| Laparoscopic partial removal of the spleen for hypersplenism in cirrhosis. | — | Yangzhou, Jiangsu | Recruiting | Oct 3, 2025 |
| ProspEXPO: How exposome factors relate to liver cancer risk in cirrhosis | — | Angers and 3 other locations | Recruiting | Aug 13, 2025 |
| Using deep learning and Raman spectroscopy for early cancer diagnosis | — | Nanchang, Jiangxi and 3 other locations | Recruiting | Feb 12, 2025 |
All recruiting trials (5)
-
Allopurinol to prevent complications in decompensated liver cirrhosis
This trial tests whether allopurinol can reduce complications in adults with decompensated cirrhosis.
-
Vonoprazan to prevent ulcers after endoscopic variceal band ligation
This trial tests whether taking vonoprazan 20 mg once daily for 14 days after variceal band ligation can reduce ulcers and swallowing pain in adults with liver cirrhosis compared with a placebo.
-
Laparoscopic partial removal of the spleen for hypersplenism in cirrhosis.
This test tries whether removing part of the spleen by laparoscopy improves immune function and recovery in people with cirrhosis and hypersplenism.
-
ProspEXPO: How exposome factors relate to liver cancer risk in cirrhosis
This study collects blood, urine, and stool samples from people with liver cirrhosis to see how environmental and lifestyle factors might influence the development of liver cancer (HCC).
-
Using deep learning and Raman spectroscopy for early cancer diagnosis
This study is trying to see if a new deep learning tool using blood samples can help spot early signs of different types of cancer, like colorectal and gastric cancers, in both healthy people and those already diagnosed.
Related topics
Quick answers
How many Cirrhoses, Liver clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in China (2 trials), France (1 trial), Pakistan (1 trial), Bangladesh (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.